Assessment of the feed additive consisting of Saccharomyces cerevisiae CBS 493.94 (Yea‐Sacc®) for dairy cows, minor dairy ruminant species, cattle for fattening and minor ruminant species for fattening for the renewal of its authorisation (ALL‐TECHNOLOGY (IRELAND) LIMITED [Alltech Ireland])

Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of a preparation of dried cells of Saccharomyces cerevisiae CBS 493.94 (Yea‐Sacc®) as a zootechnical additive for dairy cows, mi...

Full description

Saved in:
Bibliographic Details
Main Authors: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Ilen Röhe, Katerina Theodoridou, Montserrat Anguita, Jaume Galobart, Matteo L. Innocenti, Rosella Brozzi
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:EFSA Journal
Subjects:
Online Access:https://doi.org/10.2903/j.efsa.2025.9354
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of a preparation of dried cells of Saccharomyces cerevisiae CBS 493.94 (Yea‐Sacc®) as a zootechnical additive for dairy cows, minor dairy ruminant species, cattle for fattening and minor ruminant species for fattening. The feed additive is marketed in two solid forms (Yea‐Sacc® C and Yea‐Sacc® TS) differing by the granulometry. The applicant provided evidence that the additive currently in the market complies with the existing terms of the authorisation. The Panel concluded that the additive remains safe for the target species, consumers and the environment. Regarding the safety for the user, Yea‐Sacc® TS is non‐irritant to the skin or eyes while Yea‐Sacc® C is not irritant to the skin but irritant to the eyes. The additive in both formulations should be considered a skin and respiratory sensitiser and any exposure through skin and respiratory tract is considered a risk. There is no need to assess the efficacy of the additive in the context of the renewal of the authorisation.
ISSN:1831-4732